Adaptive Biotechnologies ADPT Mrd Business — Adjusted Ebitda

Similar metrics at other companies

CLFOther Businesses — Adjusted EBITDA

$15M+50.0%

CZRManaged And Branded — Adjusted EBITDA

$13M-18.8%

JLLReal Estate Management Services — Adjusted EBITDA

$65.4M+7.2%

LUMNBusiness — Total segment adjusted EBITDA

$1.13B-2.0%

JLLInvestment Management — Adjusted EBITDA

$15M-5.1%

JLLAdjusted EBITDA

$273.6M+21.7%

Questions, answered.

What is Adaptive Biotechnologies's mrd business — adjusted ebitda?

Adaptive Biotechnologies (ADPT) reported mrd business — adjusted ebitda of $12.14M in Q1 2026.

How has Adaptive Biotechnologies's mrd business — adjusted ebitda changed year-over-year?

Adaptive Biotechnologies's mrd business — adjusted ebitda increased by 395.3% year-over-year, from -$4.11M to $12.14M.

What is the long-term trend for Adaptive Biotechnologies's mrd business — adjusted ebitda?

Over 3 years (2022 to 2025), Adaptive Biotechnologies's mrd business — adjusted ebitda has grown at a -36.9% compound annual growth rate (CAGR), from -$60.5M to $15.19M.

What does mrd business — adjusted ebitda mean?

This is a non-GAAP measure of the MRD business segment's operating performance, calculated by adding back non-cash and non-recurring expenses to the segment's operating income. It provides a clearer view of the segment's core cash-generating capability by excluding accounting distortions.